Literature DB >> 24877581

Overestimated value of (18)F-FDG PET/CT to diagnose pulmonary nodules: Analysis of 298 patients.

S Li1, B Zhao1, X Wang2, J Yu2, S Yan1, C Lv1, Y Yang3.   

Abstract

AIM: To investigate the accuracy and efficacy of combined 2-[(18)F]-fluoro-2-deoxy-d-glucose (FDG) positron-emission tomography (PET)/computed tomography (CT) in the diagnosis of pulmonary nodules.
MATERIAL AND METHODS: The present retrospective study included 298 patients with clinically suspected pulmonary malignancy who underwent preoperative PET/CT. The results of PET/CT were compared with the histopathological findings after thoracotomy or thoracoscopic surgery.
RESULTS: Of 298 patients, pulmonary malignancy was histopathologically diagnosed in 248 and benign lesions in 50 patients. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of PET/CT in detecting malignant lesions were 80.2%, 38%, 86.5%, 27.9%, and 73.1%, respectively. The specificity and NPV were very low, and the area under curve (AUC) in the receiver operating characteristic (ROC) curve analysis was 0.694. For 219 patients with non-small cell lung cancer (NSCLC), falsely negative results occurred in 43 patients. The multivariate risk-factor analysis identified high differentiation (p < 0.001), peripheral lung cancer (p = 0.016), non-pleural invasion (p = 0.001), tumour size ≤3 cm (p = 0.026), adenocarcinoma (p = 0.062) and non-smoker (p = 0.066) as risk factors for false negatives..
CONCLUSION: The study suggests that the role of PET/CT in the detection of pulmonary malignancy has been overestimated in the past. It warrants attention that high differentiation, peripheral lung cancer, non-pleural invasion, tumour size ≤3 cm, adenocarcinoma, and non-smoker were independent risk factors for negative PET/CT findings of NSCLC..
Copyright © 2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24877581     DOI: 10.1016/j.crad.2014.04.007

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  9 in total

1.  Performance of FDG-PET/CT in solitary pulmonary nodule based on pre-test likelihood of malignancy: results from the ITALIAN retrospective multicenter trial.

Authors:  Laura Evangelista; Alberto Cuocolo; Leonardo Pace; Luigi Mansi; Silvana Del Vecchio; Paolo Miletto; Silvia Sanfilippo; Sara Pellegrino; Luca Guerra; Giovanna Pepe; Giuseppina Peluso; Marco Salvatore; Rosj Galicchio; Michele Zuffante; Salvatore Annunziata; Mohsen Farsad; Agostino Chiaravalloti; Marco Spadafora
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-07       Impact factor: 9.236

2.  [Combined use of thin-section CT and 18F-FDG PET/CT for characterization of solitary pulmonary nodules].

Authors:  Yun-Yan Ren; You-Cai Li; Hu-Bing Wu; Quan-Shi Wang; Yan-Jiang Han; Wen-Lan Zhou; Hong-Sheng Li; Zhen Wang; Mohammed Shah Alam Mohammed Shah Alam
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-03-20

3.  Comparing the diagnostic value of 18F-FDG-PET/CT versus CT for differentiating benign and malignant solitary pulmonary nodules: a meta-analysis.

Authors:  Yuzhu Jia; Wanfeng Gong; Zhiping Zhang; Gaofeng Tu; Jiapeng Li; Fanfan Xiong; Hongtao Hou; Yunyi Zhang; Meiqian Wu; Liping Zhang
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

4.  18F-fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis of benign pulmonary lesions in sarcoidosis.

Authors:  Ming Zhao; Xiao-Feng Xin; Huan Hu; Xian-Hui Pan; Tang-Feng Lv; Hong-Bing Liu; Jian-Ya Zhang; Yong Song
Journal:  Transl Lung Cancer Res       Date:  2019-06

5.  Diagnostic performance of fluorine-18 fluorodeoxyglucose positron emission tomography in the management of solitary pulmonary nodule: a meta-analysis.

Authors:  Duilio Divisi; Mirko Barone; Luca Bertolaccini; Gino Zaccagna; Francesca Gabriele; Roberto Crisci
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

6.  Ratio of lymph node to primary tumor SUVmax multiplied by maximal tumor diameter on positron emission tomography/integrated computed tomography may be a predictor of mediastinal lymph node malignancy in lung cancer.

Authors:  Yi Liu; Yanhua Tang; Zhiqiang Xue; Ping Yang; Kefeng Ma; Guangyu Ma; Xiangyang Chu
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

7.  The value of 18F-FDG-PET/CT in the diagnosis of solitary pulmonary nodules: A meta-analysis.

Authors:  Zhen-Zhen Li; Ya-Liang Huang; Hong-Jun Song; You-Juan Wang; Yan Huang
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889

8.  Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA).

Authors:  Wenhua Liang; Yue Zhao; Weizhe Huang; Yangbin Gao; Weihong Xu; Jinsheng Tao; Meng Yang; Lequn Li; Wei Ping; Hui Shen; Xiangning Fu; Zhiwei Chen; Peter W Laird; Xuyu Cai; Jian-Bing Fan; Jianxing He
Journal:  Theranostics       Date:  2019-04-06       Impact factor: 11.556

9.  Evaluation of dual-energy and perfusion CT parameters for diagnosing solitary pulmonary nodules.

Authors:  Beilin Zhu; Shuo Zheng; Tao Jiang; Bin Hu
Journal:  Thorac Cancer       Date:  2021-08-18       Impact factor: 3.500

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.